August 06, 2024 / 14:53 IST
Reported Consolidated quarterly numbers for Suven Life Sciences are:Net Sales at Rs 1.01 crore in June 2024 down 73.51% from Rs. 3.80 crore in June 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 28.04 crore in June 2024 down 16.39% from Rs. 24.09 crore in June 2023.
EBITDA stands negative at Rs. 26.53 crore in June 2024 down 18.54% from Rs. 22.38 crore in June 2023.
Suven Life Sci shares closed at 135.23 on August 05, 2024 (NSE) and has given 24.18% returns over the last 6 months and 116.37% over the last 12 months.
| Suven Life Sciences | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 1.01 | 2.45 | 2.61 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1.01 | 2.45 | 2.61 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.69 | 5.79 | 3.93 | | Depreciation | 1.49 | 1.60 | 1.67 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | 41.62 | 28.90 | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 26.85 | 1.23 | 1.29 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -32.02 | -47.80 | -33.19 | | Other Income | 4.01 | 6.07 | 5.60 | | P/L Before Int., Excpt. Items & Tax | -28.02 | -41.73 | -27.59 | | Interest | 0.02 | 0.04 | 0.05 | | P/L Before Exceptional Items & Tax | -28.04 | -41.76 | -27.64 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -28.04 | -41.76 | -27.64 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -28.04 | -41.76 | -27.64 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -28.04 | -41.76 | -27.64 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -28.04 | -41.76 | -27.64 | | Equity Share Capital | 21.81 | 21.81 | 21.81 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.29 | -1.92 | -1.17 | | Diluted EPS | -1.29 | -1.92 | -1.17 | | EPS After Extra Ordinary | | Basic EPS | -1.29 | -1.92 | -1.17 | | Diluted EPS | -1.29 | -1.92 | -1.17 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
